Cardiovascular risk and metabolic syndrome at the Toledo area study;Riesgo cardiovascular y síndrome metabólico en el Estudio Área de Toledo

Nutricion Hospitalaria

Volumn 24, Issue 2, 2009, Pages 167-175

  Martinez Sesmero J M ^a   Bastida, S ^b   Sanchez Muniz F J ^c  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b INSTITUTO DEL FRÍO CSIC   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Poblaci n pedi trica; Riesgo cardiovascular; S ndrome metab lico

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENTERIC FEEDING; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SPAIN; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK FACTORS; SPAIN;

EID: 64849100361     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH; American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
2. Barker DJP. The fetal origins of coronary heart disease. Acta Paediatr 1997; 422: 78-82.
3. Juonala M, Viikari JS, Rasanen L, Helenius H, Pietikainen M, Raitakari OT. Young adults with family history of coronary heart disease have increased arterial vulnerability to metabolic risk factors: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2006; 26: 1376-1382.
4. Plaza Pérez I, Villar Álvarez F, Mata López P y cols. Control of cholesterolemia in Spain, 2000. A tool for cardiovascular prevention] Rev Esp Cardiol 2000; 53: 815-837.
5. Mokdad A, Ford E, Bowman B y cols. Prevalence of obesity, diabetes, and obesity-related helth risk factors. JAMA 2001; 289: 76-79.
6. Reaven GM. Banting lecture 1988. Role of insulin resitance in human disease. Diabetes 1988; 37: 1595-1605.
7. Meigs JB. Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000; 152: 908-911.
8. Levitt NS, Lambert EV. The foetal origins of the metabolic syndrome-a South African perspective. Cardiovasc J S Afr 2002; 13: 179-180.
9. Ozanne SE, Hales CN. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab 2002; 13: 368-373.
10. Falkner B, Hassink S, Ross J, Gidding S. Dysmetabolic syndrome: multiple risk factors for premature adult disease in an adolescent girl. Pediatrics 2002; 110 (1 Pt 1): e14.
11. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR et al.Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000; 136: 664-672.
12. Ehtisham S, Barrett TG, Shaw NJ.Type 2 diabetes mellitus in UK children-an emerging problem. Diabet Med 2000; 17: 867-871.
13. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J 2002; 16: 1348-60.
14. Bastida S, Sánchez-Muniz FJ, Cuena R, Aragones A, Bravo C. Lipid and lipoprotein concentrations at age 4. Association with neonatal and parental levels. Med Clin (Barc) 2007; 128 (14): 521-8.
15. Moreiras-Varela O, Carvajal A, Cabrera L, Cuadrado C. Tablas de Composición de Alimentos. Pirámide. Madrid (2001).
16. Departamento de Nutrición. UCM. Ingestas recomendadas para la población española (revisadas en 1998). En: Moreiras O, Carbajal A, Cabrera L, Cuadrado C: Tablas de composición de alimentos. Ediciones Pirámide, Madrid, 1999.
17. Connor S, Guftanson JR, Artaud-Wild SM y cols. The cholesterol/saturated- fat index: an indication of the hypercholesterolaemic and atherogenic potential of food. Lancet 1986; 1 (8492): 1229-1232.
18. Finley PR, Schifman RB, Williams RJ, Lichtti DA. Clin Chem 1978; 24: 931-932.
19. Alexander CM, Landsman PB, Teutsch SM, Haffner SM; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP- defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214.
20. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents. Findings from the third National Health and Nutrition Examination Survey, 1988-1994. Archives of Pediatric Adolescent Medicine 2003; 157: 821-827.
21. De Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence the metabolic syndrome in American Adolescents: findings from the third National Health and Nutrition Examination Survey. Circulation 2004; 110: 2494-2497.
22. Grupo Cooperativo Español para el Estudio de los Factores de Riesgo Cardiovascular en la Infancia y Adolescencia. Factores de riesgo cardiovascular en la infancia y adolescencia en España. Estudio Ricardin II: Valores de referencia. An Esp Pediatr 1995; 43: 11-17.
23. López Martínez D, Gil A, Porres A, Blazquez E, Montoya T, Vivanco F, Álvarez-Sala L, Gómez Gerique JA, De Oya M. Perfil lipoproteico en niños y adolescentes de la Comunidad Autónoma de Madrid. Med Clin (Barc) 1996; 107: 366-370.
24. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus. Diabetes Care 2003; 26 (Supl. 1): S5-S20.
25. Garcńs C, Lasunción MA, Ortega H, López Cubero L, Benavente M, Rubio R, Del Barrio JL, Rodríguez Artalejo F, Gómez Coronado D, Oya M. Factores Metabólicos en la población escolar asociados a mortalidad cardiovascular en adultos. Estudio Cuatro Provincias. Med Clin (Barc) 2002; 118: 767-770.
26. Cole TJ, Bellizi MC, Flegal KM, Dietz WH. Establishing a Standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
27. Boyd GS, Koenigsberg J, Falkner B, Gidding S, Hassink S. Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics 2005; 116 (2): 442-6.
28. Serra Majem L, Ribas Barba L, García Closas R, Pńrez Rodrigo C, Peña Quintana L, Aranceta Bartrina J. Hábitos alimentarios y consume de alimentos en la población infantil española (1998-2000): variables socioeconómicas y geográficas. En Alimentación infantil y juvenil. Estudio enKid, Serra majem L y Aranceta Bartrina J (eds.). Masson, Barcelona, 2002, pp. 13-28.
29. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74.
30. López-Capape M, Alonso M, Colino E, Mustieles C, Corbaton J, Barrio R. Frequency of the metabolic syndrome in obese Spanish pediatric population. Eur J Endocrinol 2006; 155: 313-319.
31. Banegas JR, Ruilope LM. Epidemia de enfermedades metabó- licas. Una llamada de atención. Med Clin [Barc] 2003; 120: 99-100.
32. Ascaso JF, Fernández-Cruz A, Gonzalez Santos P y cols. HDL Forum. Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum. Am J Cardiovasc Drugs 2004; 4: 299-314.